Erasca, Inc. (ERAS)
NASDAQ·Healthcare·Biotechnology
$9.75
-49.09%
Mkt Cap $6.73B
Analyst Ratings
Buy
11
Hold
0
Sell
0
Price Target (14 analysts)
$11.60
Range $5.00 – $20.00
Implied Upside
+19.0%
Consensus $11.60 vs current $9.75
NASDAQ·Healthcare·Biotechnology
$9.75
-49.09%
Mkt Cap $6.73B
Buy
11
Hold
0
Sell
0
Price Target (14 analysts)
$11.60
Range $5.00 – $20.00
+19.0%
Consensus $11.60 vs current $9.75